SCHEMBL2296673

SCHEMBL2296673

Cc1cc(C=NO)ccc1[N+](=O)[O-]

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 8/20 0.58
KMT2A Q03164 8/20 0.58
ALDH1A1 P00352 6/20 0.58
L3MBTL1 Q9Y468 3/20 0.58
MAPT P10636 10/20 0.57
LMNA P02545 2/20 0.57
HTT P42858 2/20 0.57
NPSR1 Q6W5P4 2/20 0.57
ALOX12 P18054 1/20 0.57
SMN1; SMN2 Q16637 3/20 0.52
HPGD P15428 3/20 0.52
CRHBP P24387 1/20 0.50
CRHR2 Q13324 1/20 0.50
TSHR P16473 1/20 0.50
MAPK1 P28482 2/20 0.49
CYP1A2 P05177 1/20 0.49
CYP3A4 P08684 1/20 0.49
CYP2C19 P33261 1/20 0.49
HSP90AA1 P07900 1/20 0.49
NPC1 O15118 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2296668 1.00 MEN1 (0.58) MEN1KMT2AALDH1A1L3MBTL1MAPT
SCHEMBL472740 0.87 MEN1 (0.62) MEN1KMT2AALDH1A1L3MBTL1MAPT
SCHEMBL3110503 0.87 MEN1 (0.62) MEN1KMT2AALDH1A1L3MBTL1MAPT
SCHEMBL472739 0.87 MEN1 (0.62) MEN1KMT2AALDH1A1L3MBTL1MAPT
SCHEMBL16958437 0.81 TSHR (0.54) MEN1KMT2AALDH1A1MAPTLMNA
SCHEMBL2296057 0.80 CRHBP (0.57) MEN1KMT2AALDH1A1L3MBTL1MAPT
SCHEMBL2296058 0.80 CRHBP (0.57) MEN1KMT2AALDH1A1L3MBTL1MAPT
SCHEMBL739579 0.80 ALDH1A1 (0.46) MEN1KMT2AALDH1A1L3MBTL1MAPT
SCHEMBL14919476 0.80 MAPT (0.67) MEN1KMT2AALDH1A1L3MBTL1MAPT
SCHEMBL14919475 0.80 MAPT (0.67) MEN1KMT2AALDH1A1L3MBTL1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8835428-B2 Diacylglycerol acyltransferase inhibitors Piramal Enterprises Limited (IN) 2014-09-16 US disclosed
US-20110196002-A1 DIACYLGLYCEROL ACYLTRANSFERASE INHIBITORS PIRAMAL LIFE SCIENCES LIMITED. 2011-08-11 US disclosed
US-20100130743-A1 HETEROCYCLE-SUBSTITUTED, N-PHENYL-PHTHALAMIDE DERIVATIVES, RELATED COMPOUNDS AND THEIR USE AS INSECTICIDES BAYER CROPSCIENCE AG (DE) 2010-05-27 US disclosed
US-7674807-B2 Heterocycle-substituted n-phenyl-phthalamide derivatives, related compounds and their use as insecticides BAYER CROPSCIENCE AG (DE) 2010-03-09 US disclosed
US-20070299085-A1 N1-((Pyrazol-1-Ymethyl)-2-Methylphenyl)-Phatalamide Derivatives And Related Compounds Insecticides BAYER CROPSCIENCE AG (DE) 2007-12-27 US disclosed
EP-1727804-A1 N1 - ((PYRAZOL-1-YMETHYL) -2-METHYLPHENYL)- PHATALAMIDE DERIVATIVES AND RELATED COMPOUNDS INSECTICIDES Bayer CropScience Aktiengesellschaft (DE) 2006-12-06 EP disclosed
WO-2005095351-A1 N1 - ((PYRAZOL-1-YMETHYL) -2-METHYLPHENYL)- PHATALAMIDE DERIVATIVES AND RELATED COMPOUNDS INSECTICIDES BAYER CROPSCIENCE AG (DE) 2005-10-13 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100130743-A1 HETEROCYCLE-SUBSTITUTED, N-PHENYL-PHTHALAMIDE DERIVATIVES, RELATED COMPOUNDS AND THEIR USE AS INSECTICIDES DDT, SQOR, CYP2S1 MEN1 1134/4885KMT2A 765/4885ALDH1A1 1137/4885
US-20070299085-A1 N1-((Pyrazol-1-Ymethyl)-2-Methylphenyl)-Phatalamide Derivatives And Related Compounds Insecticides CHRM1, KCNH1, DDT MEN1 823/4885KMT2A 302/4885ALDH1A1 2697/4885
US-20110196002-A1 DIACYLGLYCEROL ACYLTRANSFERASE INHIBITORS DGAT1, DGAT2, DLAT MEN1 4530/4885KMT2A 1450/4885ALDH1A1 425/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.